7. Net sales
Net sales are derived primarily from product deliveries. Total reported net sales increased by €533 million or 1.6% from 2007 to €32,918 million. While volumes increased by €898 million, or 2.8%, adverse shifts in exchange rates trimmed sales by €1,086 million, or 3.4%. Changes in selling prices contributed €534 million, or 1.6%, to the growth in business. Portfolio changes boosted sales by €187 million, or 0.6%. Portfolio changes led to the following changes in sales compared with the previous year:
2008 | |
|---|---|
€ million | |
Acquisitions | |
Sagmel Inc. (OTC business) | 54 |
Possis Medical Inc. | 41 |
BaySystems B.V. | 30 |
Others | 141 |
266 | |
Divestitures | |
Hennecke GmbH | (61) |
Others | (18 ) |
(79 ) | |
Net effect of portfolio changes | 187 |
Breakdowns of net sales by segment and by region are given in the table in Note [1].
back to overview
back to overview


Overview
Notes
Bayer Links
Investor Relations

Bookmark this page
E-mail this page
Advanced Search



